13-year-old Terry Emmanuel Louise was at risk of heart failure as he was not able to get a heart transplant amid the COVID-19 pandemic. Our team at Gleneagles Global Health City, Chennai, successfully performed a left ventricular assist device (LVAD) implantation surgery, allowing Terry’s heart to keep functioning while he awaits a heart transplant.
Terry suffers from cardiomyopathy, a disease of the heart muscle which makes it harder for the heart to pump blood to the rest of the body, potentially leading to heart failure. He was repeatedly admitted to the hospital with symptoms of fluid overload which required inotropic infusion and intravenous diuretics.
As a heart transplant was not immediately possible amid the COVID-19 pandemic, the LVAD implant was the only option to prevent his condition from deteriorating further.
For this procedure, a ventricular assist device (VAD) was implanted in Terry’s left ventricle. It is a mechanical pump that supports heart function and blood flow for people with weakened hearts. It stimulates a healthy heart, taking blood from a lower chamber of the heart and pumping it to the body and vital organs.
With this implantation surgery, Terry’s heart is now able to continue functioning while he waits for a donor heart.
Related Stories
Fortis Launches First Dedicated Lung Failure Clinic in Faridabad
Parkway MediCentre @ Woodleigh Expands Specialist Care with Asia Pacific Eye Centre
IHH Champions Health Literacy Through Quality Journalism
Harnessing AI to Advance Patient-Centred Healthcare
Artificial intelligence is rapidly transforming healthcare, creating new opportunities to enhance patient care, improve clinical efficiency and accelerate medical innovation.
Supporting Women's Health Through Open Conversations
On 10 July, the Federation of Indian Chambers of Commerce & Industry Ladies Organisation (FICCI FLO), in partnership with Fortis Healthcare, hosted Menopause 360°: Body, Mind and Hormones, an initiative dedicated to raising awareness and encouraging open conversations around menopause.
IHH Laboratories D.N.A. Award
Discovery. Nurturing. Accuracy. The IHH Labs D.N.A. Award returns in 2026 to recognise medical technologists whose work forms a vital part of quality patient care.
